SEC INSIDER TRANSACTIONS

INTUITIVE SURGICAL INC (ISRG) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

ISRG · INTUITIVE SURGICAL INC

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-10-27 · 24 filings · fetched 2026-10-27T16:20:31Z

Recent reported activity

0purchase rows on this page

17sale rows on this page

78matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-08-11Filed 2026-08-12	GUTHART GARY SDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	10,000D	400	Indirectby Trust	Form 4 ↗0001280628-26-000014
2026-08-10Filed 2026-08-11	Ladd Amy LDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 15, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	400D	379	Direct	Form 4 ↗0001781750-26-000006
2026-08-10Filed 2026-08-10	LOEB GARYOfficer · EVP & Chief Legal and Complian Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on January 29, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	400D	379	Direct	Form 4 ↗0001561733-26-000014
2026-07-31Filed 2026-07-31	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	28D	351	Direct	Form 4 ↗0002010300-26-000025
2026-07-30Filed 2026-07-31	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	28D	346.83	Direct	Form 4 ↗0002010300-26-000025
2026-07-29Filed 2026-07-29	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	28D	360.21	Direct	Form 4 ↗0002010300-26-000023
2026-07-28Filed 2026-07-29	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	28D	365.58	Direct	Form 4 ↗0002010300-26-000023
2026-07-27Filed 2026-07-29	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	28D	344	Direct	Form 4 ↗0002010300-26-000023
2026-07-10Filed 2026-07-13	Rosa David J.Director · Officer · Chief Executive Officer (CEO) Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. F2 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. References: F2	M Exercise / conversionRestricted Stock Units · Derivative	1,910D	0	Direct	Form 4 ↗0001519593-26-000012
2026-07-10Filed 2026-07-13	Rosa David J.Director · Officer · Chief Executive Officer (CEO) Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. F2 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. References: F1	F WithholdingCommon Stock · Non-derivative	947D	411.55	Direct	Form 4 ↗0001519593-26-000012
2026-07-10Filed 2026-07-13	Rosa David J.Director · Officer · Chief Executive Officer (CEO) Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. F2 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. References: F1	M Exercise / conversionCommon Stock · Non-derivative	1,910A	0	Direct	Form 4 ↗0001519593-26-000012
2026-06-12Filed 2026-06-12	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	25D	414.13	Direct	Form 4 ↗0002010300-26-000021
2026-06-11Filed 2026-06-12	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	23D	412.16	Direct	Form 4 ↗0002010300-26-000021
2026-06-10Filed 2026-06-10	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	23D	424.14	Direct	Form 4 ↗0002010300-26-000019
2026-06-10Filed 2026-06-10	LOEB GARYOfficer · EVP & Chief Legal and Complian Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on January 29, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	400D	424.14	Direct	Form 4 ↗0001561733-26-000012
2026-06-10Filed 2026-06-10	Rosa David J.Director · Officer · Chief Executive Officer (CEO) Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. F2 Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock upon vesting. 25% of the RSUs shall vest on each anniversary of June 10, 2023, subject to Reporting Person's continuous service to the Issuer through each such vesting date. References: F2	M Exercise / conversionRestricted Stock Units - 6-12-23 · Derivative	1,358D	0	Direct	Form 4 ↗0001519593-26-000010
2026-06-10Filed 2026-06-10	Rosa David J.Director · Officer · Chief Executive Officer (CEO) Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. F2 Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock upon vesting. 25% of the RSUs shall vest on each anniversary of June 10, 2023, subject to Reporting Person's continuous service to the Issuer through each such vesting date. References: F1	F WithholdingCommon Stock · Non-derivative	674D	426.61	Direct	Form 4 ↗0001519593-26-000010
2026-06-10Filed 2026-06-10	Rosa David J.Director · Officer · Chief Executive Officer (CEO) Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. F2 Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock upon vesting. 25% of the RSUs shall vest on each anniversary of June 10, 2023, subject to Reporting Person's continuous service to the Issuer through each such vesting date. References: F1	M Exercise / conversionCommon Stock · Non-derivative	1,358A	0	Direct	Form 4 ↗0001519593-26-000010
2026-06-09Filed 2026-06-10	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	23D	421.13	Direct	Form 4 ↗0002010300-26-000019
2026-06-08Filed 2026-06-10	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	23D	420.12	Direct	Form 4 ↗0002010300-26-000019
2026-06-01Filed 2026-06-02	Jeddi ImanOfficer · SVP & GM da Vinci Platforms & Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 5, 2026. F2 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. References: F1, F2	M Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	5,625D	0	Direct	Form 4 ↗0002106898-26-000015
2026-06-01Filed 2026-06-02	Jeddi ImanOfficer · SVP & GM da Vinci Platforms & Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 5, 2026. F2 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. References: F1	S Sale (market/private)Common Stock · Non-derivative	5,625D	420.55	Direct	Form 4 ↗0002106898-26-000015
2026-06-01Filed 2026-06-02	Jeddi ImanOfficer · SVP & GM da Vinci Platforms & Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 5, 2026. F2 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. References: F1	M Exercise / conversionCommon Stock · Non-derivative	5,625A	76.9989	Direct	Form 4 ↗0002106898-26-000015
2026-05-22Filed 2026-05-22	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	18D	439.8	Direct	Form 4 ↗0002010300-26-000017
2026-05-21Filed 2026-05-22	Brosius MarkOfficer · EVP & Chief Mfg and Supply Cha Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. References: F1	S Sale (market/private)Common Stock · Non-derivative	18D	446.04	Direct	Form 4 ↗0002010300-26-000017

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.